Science, Discovery, Tech and Environment · 30 July 2026
AstraZeneca India to Establish Integrated Genomic Solutions Centre in Amaravati
Exam-focused facts from the 30 July 2026 current affairs briefing.
Key facts
- The Andhra Pradesh government signed an MoU with AstraZeneca India to establish an Integrated Genomic Solutions Centre in Amaravati.
- The centre will be India's first integrated precision oncology research and treatment ecosystem.
- It will use next-generation sequencing (NGS), artificial intelligence (AI), and genomic technologies for early cancer detection and personalized treatment.
- The initiative initially focuses on lung and breast cancers.
- AI-enabled X-ray systems will be installed in government hospitals to strengthen early detection of lung cancer.
- The project will be implemented under the Amaravati Quantum Valley programme.
- Reliance-backed Strand Life Sciences and Qure.ai are also involved in the collaboration.